UnknownNot Applicable

Regulation of Blood Dendritic Cells During Immune Therapy for Hymenoptera Venom Allergy

Germany20 participantsStarted 2009-06

Plain-language summary

Dendritic cells (DC) play a key role in the pathogenesis of allergic diseases. The regulation of blood dendritic cells in patients with hymenoptera venom allergy before and during immune therapy is unknown.

Who can participate

Age range16 Years – 80 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Patients with diagnosed hymenoptera venom allergy * No previous treatments for hymenoptera venom allergy Exclusion Criteria: * Treatment with immunosuppressive agents * Any malignant disease * Infections within 1 week prior to the initiation of the treatment

What they're measuring

Number of myeloid DC and plasmacytoid DC in peripheral blood

Timeframe: Directly before, 1 hour after, and 12 months after initiation of immune therapy

Trial details

NCT IDNCT00947908

SponsorUniversity of Rostock

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2010-06

View on ClinicalTrials.gov More Hymenoptera Venom Allergy trials